Page 146 - Eceptor News Today

Researchers investigated whether antibodies enhance severe acute respiratory syndrome coronavirus-2 infection.

Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine and Albert Einstein College of Medicine.

Psychedelics are now a rapidly growing area of neuroscience and clinical research, one that may produce much-needed new therapies for disorders such as depression and schizophrenia.

The brain is composed of billions of neurons-; vulnerable cells that require a protective environment to function properly.

While many people in wealthier countries have been vaccinated against Covid-19, there is still a need for vaccination in much of the world.

Up to 80% of individuals who've had COVID-19 report temporary or lasting changes in their sense of taste, and scientists are working to better understand the biological basis of why, including whether our taste buds are a direct virus target.

Researchers assessed the impact of demographic variability on the Pfizer/BioNTech BNT162b2 vaccine-induced serological immunity against SARS-CoV-2 variants of concern and variants of interest.

A new study assessed the neutralization induced by subunit vaccine boosters specific for the SARS-CoV-2 Omicron variant of concern.

Researchers demonstrate enhanced loss-of-function editing of CRISPR/Cas9 in human cells.

Researchers identify potential ACE2 inhibitors through a virtual screening protocol.